> top > docs > PubMed:26215578 > spans > 134-598 > annotations

PubMed:26215578 / 134-598 JSONTXT

Annnotations TAB JSON ListView MergeView

c_corpus

Id Subject Object Predicate Lexical cue
T20 4-20 UBERON:0000021 denotes epidermal growth
T23 4-27 Q9GU69 denotes epidermal growth factor
T21 4-27 D004815 denotes epidermal growth factor
T22 4-27 D004815 denotes epidermal growth factor
T24 4-27 GO:0005154 denotes epidermal growth factor
T30 29-32 Q95ND4 denotes EGF
T32 29-32 PR:P01133 denotes EGF
T33 29-32 P01133 denotes EGF
T34 29-32 PR:P07522 denotes EGF
T35 29-32 PR:P01132 denotes EGF
T36 29-32 Q9BEA0 denotes EGF
T37 29-32 P01132 denotes EGF
T38 29-32 P07522 denotes EGF
T40 29-32 PR:000006928 denotes EGF
T41 29-32 P26224 denotes EGF
T43 29-32 Q00968 denotes EGF
T31 29-32 CHEBI:140739 denotes EGF
T42 29-32 D004815 denotes EGF
T44 29-32 D004815 denotes EGF
T39 29-32 GO:0005154 denotes EGF
T45 44-51 CHEBI:52214 denotes ligands
T46 85-91 UBERON:0000310 denotes breast
T47 85-98 D001943 denotes breast cancer
T48 85-98 D001943 denotes breast cancer
T49 156-159 Q95ND4 denotes EGF
T51 156-159 PR:P01133 denotes EGF
T52 156-159 P01133 denotes EGF
T53 156-159 PR:P07522 denotes EGF
T54 156-159 PR:P01132 denotes EGF
T55 156-159 Q9BEA0 denotes EGF
T56 156-159 P01132 denotes EGF
T57 156-159 P07522 denotes EGF
T59 156-159 PR:000006928 denotes EGF
T60 156-159 P26224 denotes EGF
T62 156-159 Q00968 denotes EGF
T50 156-159 CHEBI:140739 denotes EGF
T61 156-159 D004815 denotes EGF
T63 156-159 D004815 denotes EGF
T58 156-159 GO:0005154 denotes EGF
T64 167-174 CHEBI:52214 denotes ligands
T65 198-204 UBERON:0000310 denotes breast
T66 198-211 D001943 denotes breast cancer
T67 198-211 D001943 denotes breast cancer
T68 277-284 CHEBI:52214 denotes ligands
T69 294-300 UBERON:0000310 denotes breast
T70 294-306 D001943 denotes breast tumor
T71 294-306 D001943 denotes breast tumor
T74 378-381 Q95ND4 denotes EGF
T76 378-381 PR:P01133 denotes EGF
T77 378-381 P01133 denotes EGF
T78 378-381 PR:P07522 denotes EGF
T79 378-381 PR:P01132 denotes EGF
T80 378-381 Q9BEA0 denotes EGF
T81 378-381 P01132 denotes EGF
T82 378-381 P07522 denotes EGF
T84 378-381 PR:000006928 denotes EGF
T85 378-381 P26224 denotes EGF
T87 378-381 Q00968 denotes EGF
T75 378-381 CHEBI:140739 denotes EGF
T86 378-381 D004815 denotes EGF
T88 378-381 D004815 denotes EGF
T83 378-381 GO:0005154 denotes EGF
T89 396-406 D066260 denotes epiregulin
T90 396-406 D066260 denotes epiregulin
T91 408-412 PR:000007171 denotes EREG
T92 408-412 PR:O14944 denotes EREG
T93 408-412 PR:Q61521 denotes EREG
T94 408-412 PR:Q9Z0L5 denotes EREG
T95 443-449 UBERON:0000310 denotes breast
T96 450-463 D063646 denotes tumorigenesis
T97 450-463 D063646 denotes tumorigenesis

UseCases_ArguminSci_Discourse

Id Subject Object Predicate Lexical cue
T2 0-134 DRI_Outcome denotes The epidermal growth factor (EGF) family of ligands has been implicated in promoting breast cancer initiation, growth and progression.
T3 135-350 DRI_Approach denotes The contributions of EGF family ligands and their receptors to breast cancer are complex, and the specific mechanisms through which different ligands regulate breast tumor initiation and growth are not well-defined.
T4 351-464 DRI_Background denotes These studies focus on the EGF family member epiregulin (EREG) as a mediator of early stage breast tumorigenesis.

PubMed_Structured_Abstracts

Id Subject Object Predicate Lexical cue
T1 0-464 BACKGROUND denotes The epidermal growth factor (EGF) family of ligands has been implicated in promoting breast cancer initiation, growth and progression. The contributions of EGF family ligands and their receptors to breast cancer are complex, and the specific mechanisms through which different ligands regulate breast tumor initiation and growth are not well-defined. These studies focus on the EGF family member epiregulin (EREG) as a mediator of early stage breast tumorigenesis.

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
26215578-0#0#10#gene2069 29-172 gene2069 denotes EGF) family of ligands has been implicated in promoting breast cancer initiation, growth and progression. The contributions of EGF family ligan
26215578-0#33#46#diseaseC0596263 438-463 diseaseC0596263 denotes tage breast tumorigenesis
26215578-2#21#24#gene1950 156-159 gene1950 denotes EGF
26215578-2#21#24#gene1950 156-159 gene1950 denotes EGF
26215578-2#63#76#diseaseC0006142 198-211 diseaseC0006142 denotes breast cancer
26215578-2#63#76#diseaseC0678222 198-211 diseaseC0678222 denotes breast cancer
26215578-2#159#171#diseaseC1458155 294-306 diseaseC1458155 denotes breast tumor
26215578-3#27#30#gene1950 378-381 gene1950 denotes EGF
26215578-3#99#112#diseaseC0596263 450-463 diseaseC0596263 denotes tumorigenesis
0#10#gene206933#46#diseaseC0596263 26215578-0#0#10#gene2069 26215578-0#33#46#diseaseC0596263 associated_with "EGF) family of ligands has been implicated in promoting breast cancer initiation, growth and progression. The contributions of EGF family ligan",tage breast tumorigenesis
21#24#gene195063#76#diseaseC0006142 26215578-2#21#24#gene1950 26215578-2#63#76#diseaseC0006142 associated_with EGF,breast cancer
21#24#gene195063#76#diseaseC0678222 26215578-2#21#24#gene1950 26215578-2#63#76#diseaseC0678222 associated_with EGF,breast cancer
21#24#gene1950159#171#diseaseC1458155 26215578-2#21#24#gene1950 26215578-2#159#171#diseaseC1458155 associated_with EGF,breast tumor
21#24#gene195063#76#diseaseC0006142 26215578-2#21#24#gene1950 26215578-2#63#76#diseaseC0006142 associated_with EGF,breast cancer
21#24#gene195063#76#diseaseC0678222 26215578-2#21#24#gene1950 26215578-2#63#76#diseaseC0678222 associated_with EGF,breast cancer
21#24#gene1950159#171#diseaseC1458155 26215578-2#21#24#gene1950 26215578-2#159#171#diseaseC1458155 associated_with EGF,breast tumor
27#30#gene195099#112#diseaseC0596263 26215578-3#27#30#gene1950 26215578-3#99#112#diseaseC0596263 associated_with EGF,tumorigenesis